A detailed history of Amundi transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Amundi holds 5,217,517 shares of EW stock, worth $347 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
5,217,517
Previous 5,519,857 5.48%
Holding current value
$347 Million
Previous $527 Million 8.63%
% of portfolio
0.19%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $25.5 Million - $28.5 Million
-302,340 Reduced 5.48%
5,217,517 $482 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $51.6 Million - $67.9 Million
-710,696 Reduced 11.41%
5,519,857 $527 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $19.7 Million - $24.8 Million
318,902 Added 5.39%
6,230,553 $475 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $104 Million - $140 Million
-1,498,503 Reduced 20.22%
5,911,651 $410 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $74.5 Million - $86.3 Million
914,993 Added 14.09%
7,410,154 $699 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $120 Million - $136 Million
-1,613,687 Reduced 19.9%
6,495,161 $537 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $114 Million - $146 Million
1,673,580 Added 26.01%
8,108,848 $605 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $95.1 Million - $124 Million
1,154,632 Added 21.87%
6,435,268 $561 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $4.14 Million - $6.15 Million
-47,911 Reduced 0.9%
5,280,636 $511 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $89.8 Million - $113 Million
881,088 Added 19.81%
5,328,547 $658 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $37.4 Million - $46 Million
-351,962 Reduced 7.33%
4,447,459 $538 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $3.05 Million - $3.63 Million
29,607 Added 0.62%
4,799,421 $543 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $400 Million - $500 Million
4,769,814 New
4,769,814 $494 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.